Pennington Generation Cohort
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Peter T Katzmarzyk, PhD
- Phone Number: 225-763-2536
- Email: peter.katzmarzyk@pbrc.edu
Study Contact Backup
- Name: Kara Denstel, PhD
- Phone Number: 763-2614
- Email: kara.denstel@pbrc.edu
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Recruiting
- Pennington Biomedical Research Center
-
Contact:
- Peter T Katzmarzyk, PhD
- Phone Number: 225-763-2536
- Email: peter.katzmarzyk@pbrc.edu
-
Principal Investigator:
- Peter T Katzmarzyk, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children, adolescents, and young adults (birth through age 24 years) and their nuclear family members* and adults age 25+ who are expectant parents or are trying to conceive
- Self-reported resident of Louisiana
- Ability to understand instructions and complete all study procedures
- Able to provide informed consent (adults aged over 18 years)
- Able to provide assent (children 9 to 17 years)
- Able to communicate (oral and written) in English
Exclusion Criteria:
- Discretion of the Medical Monitor or Principal Investigator
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Obesity
Time Frame: From enrollment up to 20 years of follow-up.
|
The development of obesity, defined using BMI z-scores during childhood, and BMI during adulthood.
|
From enrollment up to 20 years of follow-up.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight change
Time Frame: From enrollment up to 20 years of follow-up.
|
Change in body weight.
|
From enrollment up to 20 years of follow-up.
|
|
Mortality
Time Frame: From enrollment up to 20 years of follow-up..
|
Data from the Pennington Generation Prospective Cohort will be prospectively linked to the National Death Index for the ascertainment of mortality.
|
From enrollment up to 20 years of follow-up..
|
|
Cancer incidence
Time Frame: From enrollment up to 20 years of follow-up..
|
Data from the Pennington Generation Prospective Cohort will be prospectively linked to the Louisiana Tumor Registry for the ascertainment of incident cancer.
|
From enrollment up to 20 years of follow-up..
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Peter T Katzmarzyk, PhD, Pennington Biomedical Research Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024-036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.